Review of proteomics with applications to genetic epidemiology

Genetic Epidemiology

Volumn 24, Issue 2, 2003, Pages 83-98

  Sellers, Thomas A ^a   Yates, John R ^b  

^a MAYO CLINIC   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Genetics; Linkage; Physical chromosome mappling; Polymorphism; Spectrometry

Indexed keywords

ALBUMIN; CA 125 ANTIGEN; DNA MARKER; ORAL CONTRACEPTIVE AGENT;

ANALYTIC METHOD; ANIMAL TISSUE; BRAIN TISSUE; CANCER CELL; CHROMOSOMAL LOCALIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DEMOGRAPHY; DNA SEQUENCE; DNA SPLICING; ECHOMAMMOGRAPHY; GEL ELECTROPHORESIS; GENE MAPPING; GENETIC CODE; GENETIC EPIDEMIOLOGY; GENOME; GENOTYPE; HUMAN; INTERNET; LINKAGE ANALYSIS; MASS SPECTROMETRY; MEDICAL GENETICS; MOUSE; NONHUMAN; OVARY CANCER; PATIENT SELECTION; PHENOTYPE; PLASMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUALITY CONTROL; REVIEW; RISK FACTOR; SAMPLING; SEGREGATION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TECHNIQUE; TECHNOLOGY;

BREAST NEOPLASMS; CHROMOSOME MAPPING; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); MASS SPECTROMETRY; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROTEOMICS;

EID: 0037310184     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/gepi.10226     Document Type: Review

References (81)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-10.
2. Baltimore D. 2001. Our genome unveiled. Nature 409:814-6.
3. Barr JR, Maggio VL, Patterson DG Jr, Cooper GR, Henderson LO, Turner WE, Smith SJ, Hannon WH, Needham LL, Sampson EJ. 1996. Isotope dilution - mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem 42:1676-82.
4. Bishop AC, Ubersax JA, Petsch DT, Matheos DP, Gray NS, Blethrow J, Shimizu E, Tsien JZ, Schultz PG, Rose MD, Wood JL, Morgan DO, Shokat KM. 2000. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407:395-401.
5. Bishop AC, Buzko O, Shokat KM. 2001. Magic bullets for protein kinases. Trends Cell Biol 11:167-72.
6. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. 1998. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133-44.
7. Burkman RT, Collins JA, Shulman LP, Williams JK. 2001. Current perspectives on oral contraceptive use. Am J Obstet Gynecol 185:4-12.
8. Cahill DJ. 2001. Protein and antibody arrays and their medical applications. J Immunol Methods 250:81-91.
9. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yates JR III, Hays L, Morgan WF, Petrini JH. 1998. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477-86.
10. Celis A, Rasmussen HH, Celis P, Basse B, Lauridsen JB, Ratz G, Hein B, Ostergaard M, Wolf H, Orntoft T, Celis JE. 1999. Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis 20:355-61.
11. Celis JE, Gromov P. 1999. 2D protein electrophoresis: can it be perfected? Curr Opin Biotechnol 10:16-21.
12. Clegg RM. 2002. FRET tells us about proximities, distances, orientations and dynamic properties. J Biotechnol 82:177-9.
13. Collins FS. 1999. Shattuck lecture - medical and societal consequences of the Human Genome Project. N Engl J Med 341:28-37.
14. de Carvalho MG, McCormack AL, Olson E, Ghomashchi F, Gelb MH, Yates JR III, Leslie CC. 1996. Identification of phosphorylation sites of human 85-kDa cytosolic phospholipase A2 expressed in insect cells and present in human monocytes. J Biol Chem 271:6987-97.
15. Desiderio DM, Kai M. 1983. Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue. Biomed Mass Spectrom 10:471-9.
16. Drees BL, Sundin B, Brazeau E, Caviston JP, Chen GC, Guo W, Kozminski KG, Lau MW, Moskow JJ, Tong A, Schenkman LR, McKenzie A III, Brennwald P, Longtine M, Bi E, Chan C, Novick P, Boone C, Pringle JR, Davis TN, Fields S, Drubin DG. 2001. A protein interaction map for cell polarity development. J Cell Biol 154:549-71.
17. Egan R. 1988. Breast imaging: diagnosis and morphology of breast diseases. WB Saunders Company, Philadelphia.
18. Emptage NJ. 2001. Fluorescent imaging in living systems. Curr Opin Pharmacol 1:521-5.
19. Eng J, McCormack AL, Yates JR III. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 5:976-9.
20. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, Shabanowitz J, Hunt DF, White FM. 2002. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 20:301-5.
21. Figeys D, Ducret A, Yates JR III, Aebersold R. 1996. Protein identification by solid phase microextraction-capillary zone electrophoresis-microelectrospray-tandem mass spectrometry. Nat Biotechnol 14:1579-83.
22. Gatlin CL, Eng JK, Cross ST, Detter JC, Yates JR III. 2000. Automated identification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry. Anal Chem 72:757-63.
23. Geng M, Ji J, Regnier FE. 2000. Signature-peptide approach to detecting proteins in complex mixtures. J Chromatogr [A] 870:295-313.
24. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994-9.
25. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. 2000. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 97:9390-5.
26. Hayward RE, Cameron G, Kozlowski RZ. 2001. Probing the proteome - protein arrays and their applications. Drug Discov Today 6:1263-5.
27. Hazbun TR, Fields S. 2001. Networking proteins in yeast. Proc Natl Acad Sci USA 98:4277-8.
28. Houseman BT, Huh JH, Kron SJ, Mrksich M. 2002. Peptide chips for the quantitative evaluation of protein kinase activity. Nat Biotechnol 20:270-4.
29. IHGS Consortium, Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
30. International SNP Map Working Group, Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, et al. 2001. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-33.
31. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. 2001. Replication validity of genetic association studies. Nat Genet 29:306-9.
32. Jiang H, English AM. 2002. Quantitive analysis of the yeast proteome by incorporation of isotopically labeled leucine. J Proteome Res 1:345-50.
33. Kidd D, Liu Y, Cravatt BF. 2001. Profiling serine hydrolase activities in complex proteomes. Biochemistry 40:4005-15.
34. Klose J, Nock C, Herrmann M, Stuhler K, Marcus K, Bluggel M, Krause E, Schalkwyk LC, Rastan S, Brown SD, Bussow K, Himmelbauer H, Lehrach H. 2002. Genetic analysis of the mouse brain proteome. Nat Genet 30:385-93.
35. Krajinovic M, Ghadirian P, Richer C, Sinnett H, Gandini S, Perret C, Lacroix A, Labuda D, Sinnett D. 2001. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogenmetabolizing enzymes and gene-environment interactions. Int J Cancer 92:220-5.
36. Link AJ, Carmack E, Yates JR III. 1997. A strategy for the identification of protein localized to subcellular spaces application to E-coli periplasmic proteins. Int J Mass Spectrom Ion Proc 160:303-16.
37. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, Yates JR III. 1999. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17:676-82.
38. Liu Y, Patricelli MP, Cravatt BF. 1999. Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci USA 96:14694-9.
39. Lopez MF, Melov S. 2002. Applied proteomics: mitochondrial proteins and effect on function. Circ Res 90:380-9.
40. Maitra A, Wistuba II, Gazdar AF. 2001. Microdissection and the study of cancer pathways. Curr Mol Med 1:153-62.
41. Meri S, Baumann M. 2001. Proteomics: posttranslational modifications, immune responses and current analytical tools. Biomol Eng 18:213-20.
42. Mizzen CA, Allis CD. 2000. Transcription. New insights into an old modification. Science 289:2290-1.
43. Munchbach M, Quadroni M, Miotto G, James P. 2000. Quantitation and facilitated de novo sequencing of proteins by isotopic N-terminal labeling of peptides with a fragmentation-directing moiety. Anal Chem 72:4047-57.
44. Oda Y, Huang K, Cross FR, Cowbum D, Chait BT. 1999. Accurate quantitation of protein expression and site-specific phosphorylation. Proc Natl Acad Sci USA 96:6591-6.
45. Oda Y, Nagasu T, Chait BT. 2001. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol 19:379-82.
46. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin EF III, Emmert-Buck MR. 2000. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21:2235-42.
47. Oza AM, Boyd NF. 1993. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 15:196-208.
48. Ozols R, Rubin S, Thomas G, Robboy S. 2000. Epithelial ovarian cancer. In: Hoskins W, Perez C, Young R, editors. Principles and practice of gynecologic oncology. Philadelphia: Lippincott Williams and Wilkins. p 981-1058.
49. Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA. 1997. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst 89:549-56.
50. Pertsemlidis A, Fondon JW III. 2001. Having a BLAST with bioinformatics (and avoiding BLASTphemy). Genome Biol 2 2002.1-2002.10.
51. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. 2002. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-7.
52. Poly WJ. 1997. Nongenetic variation, genetic-environmental interactions and altered gene expression. III. Posttranslational modifications. Comp Biochem Physiol [A] 118:551-72.
53. Pratt JM, Petty J, Riba-Garcia I, Robertson DH, Gaskell SJ, Oliver SG, Beynon RJ. 2002. Dynamics of protein turnover, a missing dimension in proteomics. Mol Cell Proteomics 1:579-91.
54. Risch HA, Marrett LD, Howe GR. 1994. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 140:585-97.
55. Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405:847-56.
56. S.A.G.E. 2002. Statistical analysis for genetic epidemiology. Cork, Ireland: Statistical Solutions, Ltd.
57. Schaid DJ, McDonnell SK, Thibodeau SN. 2001. Regression models for linkage heterogeneity applied to familial prostate cancer. Am J Hum Genet 68:1189-96.
58. Schwikowski B, Uetz P, Fields S. 2000. A network of protein-protein interactions in yeast. Nat Biotechnol 18:1257-61.
59. Shen Y, Xiang F, Veenstra TD, Fung EN, Smith RD. 1999. High-resolution capillary isoelectric focusing of complex protein mixtures from lysates of microorganisms. Anal Chem 71: 5348-53.
60. Stemmann O, Zou H, Gerber SA, Gygi SP, Kirschner MW. 2001. Dual inhibition of sister chromatid separation at metaphase. Cell 107:715-26.
61. Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403:41-5.
62. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfleisch T, Vijayadamodar G, Yang M, Johnston M, Fields S, Rothberg JM. 2000. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403:623-7.
63. Uy R, Wold F. 1977. Posttranslational covalent modification of proteins. Science 198:890-6.
64. Vachon CM, King RA, Atwood LD, Kuni CC, Sellers TA. 1999. Preliminary sibpair linkage analysis of percent mammographic density. J Natl Cancer Inst 91:1778-9.
65. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-6.
66. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, et al. 2001. The sequence of the human genome. Science 291:1304-51.
67. Vihinen M. 2001. Bioinformatics in proteomics. Biomol Eng 18:241-8.
68. von Mering C, Krause R, Snel B, Cornell M, Oliver SG, Fields S, Bork P. 2002. Comparative assessment of large-scale data sets of protein-protein interactions. Nature 417:399-403.
69. Warner E, Lockwood G, Tritchler D, Boyd NE 1992. The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev 16:67-72.
70. Washburn MP, Wolters D, Yates JR III. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19:242-7.
71. Washburn MP, Ulaszek R, Deciu C, Schieltz DM, Yates JR III. 2002. Analysis of quantitative proteomic data generated via multidimensional protein identification technology. Anal Chem 74:1650-7.
72. Whittemore AS, Harris R, Itnyre J. 1992. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136:1184-203.
73. Wolfe J, Albert S, Belle S, Salane M. 1980. Familial influences on breast parenchymal patterns. Cancer 1201:2433-7.
74. Wu CC, Yates JR III, Neville MC, Howell KE. 2000. Proteomic analysis of two functional states of the Golgi complex in mammary epithelial cells. Traffic 1:769-82.
75. Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C. 2001. Proteolytic 180 labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal Chem 73:2836-42.
76. Yates JR III. 1998. Mass spectrometry and the age of the proteome. J Mass Spectrom 33:1-19.
77. Yates JR III. 2000. Mass spectrometry. From genomics to proteomics. Trends Genet 16:5-8.
78. Yates JR III, Eng JK, McCormack AL. 1995. Mining genomes: correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases. Anal Chem 67:3202-10.
79. Zhou H, Roy S, Schulman H, Natan MJ. 2001a. Solution and chip arrays in protein profiling. Trends Biotechnol 19:34-39.
80. Zhou H, Watts JD, Aebersold R. 2001b. A systematic approach to the analysis of protein phosphorylation. Nat Biotechnol 19:375-8.
81. Zhu H, Snyder M. 2001. Protein arrays and microarrays. Curr Opin Chem Biol 5:40-5.